6 Matching Annotations
  1. Last 7 days
  2. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov
    Combinatorial immunotherapy with agonistic CD40 activates dendritic cells to express IL12 and overcomes PD-1 resistance
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    pmc.ncbi.nlm.nih.gov/articles/PMC12645833/
  3. Feb 2025
  4. 52.53.155.43 52.53.155.43
    Mapping intratumoral myeloid-T cell interactomes at single-cell resolution reveals targets for overcoming checkpoint inhibitor resistance
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    52.53.155.43/b97c57717b8e9ffd85392521b55861178592850c/2024.10.28.620093.full-html.html
  5. Nov 2023
  6. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    A bedside to bench study of anti-PD-1, anti-CD40, and anti-CSF1R indicates that more is not necessarily better
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC10644655/
  7. Apr 2023
  8. aacrjournals.org aacrjournals.org
    Targeting ULK1 decreases interferon-γ-mediated resistance to immune checkpoint inhibitors
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    aacrjournals.org/mcr/article/21/4/332/718954/Targeting-ULK1-Decreases-IFN-Mediated-Resistance
  9. insight.jci.org insight.jci.org
    Lenvatinib or anti-VEGF in combination with anti-PD-1 differentially augments anti-tumor activity in melanoma
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    insight.jci.org/articles/view/157347
  10. Jan 2023
  11. www.sciencedirect.com www.sciencedirect.com
    S-adenosylmethionine blocks tumorigenesis and with immune checkpoint inhibitor enhances anti-cancer efficacy against BRAF mutant and wildtype melanomas
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S1476558622000999